Skip Navigation

Children's Mercy Hospital

Location

Children's Mercy Hospital
Blood and Marrow Transplant Program
2401 Gillham Road
Kansas City, MO 64118
Direct phone: (816) 302-6808
Toll-free: (800) 236-1713

Total transplants by cell source

From January 1, 2021 to December 31st, 2022
  • Marrow: 25
  • PBSC: 7
  • Cord Blood: 6
  • Autologous (PBSC or Marrow): 20
Performs pediatric transplants

Overview

The Children's Mercy Hospital's Blood and Bone Marrow Transplant Program treats children and young adults utilizing all donor sources. The program performs transplants for patients with a variety of childhood cancers including leukemia, lymphoma, neuroblastoma, and other solid cancers. The program is focused on novel less toxic transplant approaches to treat patients with non-malignant diseases, such as severe combined immunodeficiency (SCID), aplastic anemia, thalassemia, sickle cell disease, neurometabolic diseases, and other rare genetic disorders.

This center has been performing allogeneic transplants since 1995 and has been an NMDP/Be The Match transplant center since February 2007.

Attending physicians

Adult - Ibrahim Ahmed, Erin M. Hall, G. Doug Myers

Pediatric - Ibrahim Ahmed, Erin M. Hall, G. Doug Myers

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants performed on

Pediatric only

Other programs and services

Ronald McDonald housing is available on the Children's Mercy Hospital campus. Hotel accommodations are also available within close proximity to the hospital. The Hem/Onc/BMT division offers a parent to parent program to connect parents with similar experiences for support. We also offer special child life events. Meditation and religious services are also available.

About the center

Overview

The Children's Mercy Hospital's Blood and Bone Marrow Transplant Program treats children and young adults utilizing all donor sources. The program performs transplants for patients with a variety of childhood cancers including leukemia, lymphoma, neuroblastoma, and other solid cancers. The program is focused on novel less toxic transplant approaches to treat patients with non-malignant diseases, such as severe combined immunodeficiency (SCID), aplastic anemia, thalassemia, sickle cell disease, neurometabolic diseases, and other rare genetic disorders.

This center has been performing allogeneic transplants since 1995 and has been an NMDP/Be The Match transplant center since February 2007.

Attending physicians

Adult - Ibrahim Ahmed, Erin M. Hall, G. Doug Myers

Pediatric - Ibrahim Ahmed, Erin M. Hall, G. Doug Myers

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants performed on

Pediatric only

Other programs and services

Ronald McDonald housing is available on the Children's Mercy Hospital campus. Hotel accommodations are also available within close proximity to the hospital. The Hem/Onc/BMT division offers a parent to parent program to connect parents with similar experiences for support. We also offer special child life events. Meditation and religious services are also available.

Overall center survival


Patient survival information for this center

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 51 patients.

The actual 1-year survival of these patients is 94.1%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 77.7% and 95.6%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

Total transplants

Total transplants


58

Transplants reported (From January 1, 2021 to December 31st, 2022 as reported by the centers)

Marrow PBSC Cord blood Total
Allogeneic
Related donor 16 2 0 18
Unrelated donor 9 5 6 20
Total allogeneic 25 7 6 38
Autologous
Both marrow & PBSC
20
-- 20
Total combined
52 6 58

Transplants by disease

All diseases

Number of transplants by age reported from January 1, 2021 to December 31st, 2022 (includes marrow, PBSC and cord blood)

0-18 19-44 45-64 65+ Total
Related 16 0 0 0 16
Unrelated 19 1 0 0 20
Autologous 19 1 0 0 20
Total 54 2 0 0 56

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants for this disease can be found:

Additional information

Transplant center resources

Transplant center coordinator:
Kimberly Miller
(913) 687-0070
Email: kkmiller@cmh.edu

If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.

NMDP patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743

Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

Survivorship program

Loading survivorship program information...